Key result
Alprostadil infusion during extracorporeal circulation reduced postoperative blood loss at 12 and 24 hours and preserved blood rheology.
Why the study?
Does alprostadil infusion during extracorporeal circulation improve blood rheology and reduce postoperative blood loss in patients undergoing aortocoronary bypass?
Does alprostadil infusion during extracorporeal circulation improve blood rheology and reduce postoperative blood loss in patients undergoing aortocoronary bypass?
Low-dose alprostadil infusion during extracorporeal circulation preserves blood rheology and significantly reduces postoperative blood loss and transfusion requirements in CABG patients.
Answers are grounded in this paper and cite their sources.
May reduce blood loss in CABG; hypothesis-generating and should not yet change practice.
The authors have investigated the effects a low dose of alprostadil (synthetic prostaglandin E 1 : S-PGI 1 ) infusion during cardiac surgery on blood rheology and postoperative blood loss. S-PGE 1 (20 ng/kg/minute) was given to 13 patients undergoing aortocoronary bypass. Another 13 patients who received no S-PGE 1 during bypass surgery served as controls. To assess blood rheology, blood samples for red and white cell filterability (RFR and WFR) and for platelet count were collected preoperatively, immediately after the end of extracorporeal circulation (ECC), and twenty-four hours later. Records of blood loss were taken twelve and twenty-four hours postoperatively. RFR, WFR, and platelet counts at twenty-four hours were significantly reduced in the control group as compared with the S-PGE 1 group, p = 0.002, p = 0.004, and p = 0.0026, respectively. Concomitantly, the means of the postoperative blood loss at twelve and twenty-four hours were lower in the S-PGE 1 group, p= 0.0001 and p=0.0004, respectively. Furthermore, the use of blood transfusion products was significantly less in the S-PGE, group, p < 0.02. These results showed that the use of S-PGE, during ECC preserves blood rheology in association with significant reductions in blood loss and in the need for blood transfusion postoperatively.
No takes yet. Share an insight, caveat, or question.
El-Gatit et al. (1992) studied Patients undergoing aortocoronary bypass (n=26). Alprostadil (synthetic prostaglandin E1) vs. No alprostadil was evaluated on Postoperative blood loss at 12 and 24 hours (p=0.0001). Alprostadil infusion during extracorporeal circulation reduced postoperative blood loss at 12 and 24 hours and preserved blood rheology.
Synapse has enriched 10 related papers. Consider them for comparative context: